The GiveWell Blog

Trachoma: An example of the need for long-term monitoring

When is a measured program-impact not a real impact? When it doesn’t last. A study published today in PloS NTDs evaluated the impact of four doses of azithromycin (one every 6 months), and monitored trachoma prevalence throughout the drug administration period and for 2 years after the last dose. In the first 24 months (from…

Read More

The Carter Center

I’ve spent a good part of the past month reviewing The Carter Center in depth. We found out about The Carter Center though referrals from an advisor and donor, and through the Gates Award for Global Health. We chose to investigate The Carter Center further for four reasons: Strong track record of success. The Carter…

Read More

Malaria treatment

The Disease Control Priorities Report says: The recommended treatments for malaria in areas with resistance to single drugs are combination treatments, preferably artemisinin combination therapy (ACT) (WHO 2001a, 2001b, 2003a, 2005). But, knowing that your charity of choice runs this program is not sufficient to know that they’re improving lives. Bill Brieger at Malaria Matters…

Read More

Surgeries performed vs. cases of blindness prevented

We’ve written before about the possibility that surgeries to correct blindness are extremely cost effective. While summarizing the evidence of effectiveness for trachoma interventions, we’ve learned more and it’s clear that equating surgeries performed with cases of blindness prevented is plain wrong. I read Trachoma: an overview, a literature review of the evidence of effectiveness…

Read More

Strong results for malaria vaccine

A study published in the New England Journal of Medicine reports strong results from a clinical trial testing the efficacy of a malaria vaccine. The double-blind, randomized trial found a significant impact on malaria incidence among the group receiving the malaria vaccine. The full study is available here. The summary results: 894 children were randomly…

Read More

Finally, a competitor!

This week, The Chronicle of Philanthropy wrote an article about the creation of the Alliance for Effective Social Investing. We wholeheartedly applaud Steve Butz and other members of the Alliance for their efforts, and really hope they succeed. There are too few organizations focusing on the effectiveness of charitable programs, and we’re excited to see…

Read More